Unknown

Dataset Information

0

Confounding factors in the assessment of oral mucositis in head and neck cancer.

ABSTRACT: Treatment of locally advanced head and neck carcinoma not amenable for surgical resection or resected with high-risk features is usually based on (chemo-)radiation treatment. Oral mucositis represents one of the main side effects of (chemo-)radiation, with an important impact on quality of life and causing approximately 20% of early interruption of treatment, leading to a suboptimal dose administered. Treatment and prevention of oral mucositis have a central role in the therapeutic pathways of head and neck cancer patients but remains quite challenging. Although extensive research is conducted to identify interventions for the management of mucositis, very few interventions had sufficient evidence to generate an international expert consensus. This may be partially explained by confounding factors that could influence the development and assessment of oral mucositis. Little is known about the confounding factors of oral mucositis, which, if not well balanced in an experimental study, could lead to non-solid results. The current paper aims to review the main oral mucositis confounding factors related to head and neck cancer patients.

SUBMITTER: Lorini L 

PROVIDER: S-EPMC9512735 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Confounding factors in the assessment of oral mucositis in head and neck cancer.

Lorini Luigi L   Perri Francesco F   Vecchio Stefania S   Belgioia Liliana L   Vinches Marie M   Brana Irene I   Elad Sharon S   Bossi Paolo P  

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20220531 10

Treatment of locally advanced head and neck carcinoma not amenable for surgical resection or resected with high-risk features is usually based on (chemo-)radiation treatment. Oral mucositis represents one of the main side effects of (chemo-)radiation, with an important impact on quality of life and causing approximately 20% of early interruption of treatment, leading to a suboptimal dose administered. Treatment and prevention of oral mucositis have a central role in the therapeutic pathways of h  ...[more]

Similar Datasets

Unknown The Effect of Honey on Radiation-induced Oral Mucositis in Head and Neck Cancer Patients.
| S-EPMC5545960 | biostudies-other
Unknown Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer.
| S-EPMC8184418 | biostudies-literature
Unknown Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer.
| S-EPMC4358035 | biostudies-literature
Unknown Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice.
| S-EPMC8579069 | biostudies-literature
Unknown Status of Treatment and Prophylaxis for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer.
| S-EPMC8013721 | biostudies-literature
Unknown Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.
| S-EPMC10706892 | biostudies-literature
Unknown A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis.
| S-EPMC4822960 | biostudies-literature
Unknown Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.
| S-EPMC2376383 | biostudies-other
Unknown Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
| S-EPMC6408208 | biostudies-literature
Unknown Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
| S-EPMC8191575 | biostudies-literature